ERVW-1 and HIV infectious disease: Interestingly, the 855 dileucine mutant did not elevate surface Env relative to WT Env (Figure 4A,B), and it also did not significantly reduce the levels of HIV infection mediated through cell–cell transmission (Figure 4E,F).